Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117306) titled 'The Effect of Esketamine Combined with Sufentanil Intravenous Patient-Controlled Analgesia on Postoperative Negative Emotions and Recovery Quality in Patients Undergoing Debridement and Skin Grafting' on Jan. 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First People's Hospital of Lianyungang

Condition: Burn

Intervention: Experimental group ES group (esketamine and sufentanil):Esketamine combined with sufentanil

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-15

Target Sample Size: Experimental group ES group (esketamine and sufentani...